Concepedia

Evelien Moorkens

EM

Statistics

Publications

11

Citations

748

H-Index

11

Active since

2017

Affiliations

KU Leuven(Current)

University of Strathclyde

Karolinska Institutet

Wissenschaftliches Institut der AOK

Evelien Moorkens is an author at KU Leuven specializing in pharmaceutical policy, biosimilar use, and pharmaceutical economics.

Publications per year

2017–2022

11

Publications

11

Policies for biosimilar uptake in Europe: An overview

Evelien Moorkens, Arnold G. Vulto, Isabelle Huys et al. · PLoS ONE · 2017 · 352 citations · Full text

Pharmacy, Clinical Pharmacy, Pharmaceutical Policy +16

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape

Evelien Moorkens, Nicolas Meuwissen, Isabelle Huys et al. · Frontiers in Pharmacology · 2017 · 106 citations · Full text

Pharmacy, Biotechnology, Pharmaceutical Biotechnology +17

The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures

Evelien Moorkens, Brian Godman, Isabelle Huys et al. · Frontiers in Pharmacology · 2021 · 68 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +17

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?

Yujeong Kim, Hye-Young Kwon, Brian Godman et al. · Frontiers in Pharmacology · 2020 · 56 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacotherapy +16

Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting

Evelien Moorkens, Steven Simoens, Per Troein et al. · BioDrugs · 2019 · 34 citations · Full text

Public Affairs, Health Policy, Pharmaceutical Policy +13

1–5 of 11